Absci Corp (ABSI) stock

ABSINasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30

$8.45−0.69 (-7.50%)

Close on Nov 13, 2026Market cap $1.45BP/E –Yield –

Absci profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Absci's profit margin for the twelve months ending Sep 30, 2026 was -8451.3%. For fiscal 2025 it was -4113.7%, against -2274.1% the year before. The highest annual figure on record is -300.3% in fiscal 2020.

Annual profit margin

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	-4113.7%	−1839.6
FY2024	Dec 31, 2024	-2274.1%	−340.4
FY2023	Dec 31, 2023	-1933.6%	−108.3
FY2022	Dec 31, 2022	-1825.4%	+285.9
FY2021	Dec 31, 2021	-2111.3%	−1811.0
FY2020	Dec 31, 2020	-300.3%	–

Quarterly profit margin

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q3 FY2026	Sep 30, 2026	-10953.9%	−3359.8
Q2 FY2026	Jun 30, 2026	-10443.4%	−5288.4
Q1 FY2026	Mar 31, 2026	-13767.0%	−11532.4
Q4 FY2025	Dec 31, 2025	-4548.0%	−189.7
Q3 FY2025	Sep 30, 2025	-7594.2%	−5983.5
Q2 FY2025	Jun 30, 2025	-5155.0%	−3206.2
Q1 FY2025	Mar 31, 2025	-2234.6%	+212.5
Q4 FY2024	Dec 31, 2024	-4358.3%	+2607.6
Q3 FY2024	Sep 30, 2024	-1610.7%	+1345.5
Q2 FY2024	Jun 30, 2024	-1948.8%	−711.2
Q1 FY2024	Mar 31, 2024	-2447.1%	−606.7
Q4 FY2023	Dec 31, 2023	-6966.0%	−5715.4
Q3 FY2023	Sep 30, 2023	-2956.2%	−1805.5
Q2 FY2023	Jun 30, 2023	-1237.7%	+1624.6
Q1 FY2023	Mar 31, 2023	-1840.4%	+1760.8
Q4 FY2022	Dec 31, 2022	-1250.5%	+482.6
Q3 FY2022	Sep 30, 2022	-1150.7%	+385.0
Q2 FY2022	Jun 30, 2022	-2862.3%	+2796.8
Q1 FY2022	Mar 31, 2022	-3601.2%	−2570.0
Q4 FY2021	Dec 31, 2021	-1733.2%	−1552.1
Q3 FY2021	Sep 30, 2021	-1535.7%	−1126.5
Q2 FY2021	Jun 30, 2021	-5659.1%	−5125.7
Q1 FY2021	Mar 31, 2021	-1031.2%	–
Q4 FY2020	Dec 31, 2020	-181.0%	–
Q3 FY2020	Sep 30, 2020	-409.2%	–
Q2 FY2020	Jun 30, 2020	-533.3%	–